Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Net income | -5.3 | -5.1 | -6.9 | -7.0 | -5.4 | -6.2 | -5.3 | -6.3 |
| Depreciation and amortization [+] | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Stock-based compensation | 1.0 | 0.0 | 0.4 | 0.4 | 0.5 | 0.6 | 0.0 | 0.5 |
| Change in working capital [+] | -2.7 | 1.7 | 1.1 | 0.6 | 0.9 | 0.7 | -1.9 | 0.1 |
| Accounts payable | -2.6 | 1.6 | 1.1 | 0.7 | 0.9 | 1.0 | -0.3 | 0.4 |
| Other | -0.1 | 0.1 | 0.0 | -0.1 | 0.0 | -0.2 | -1.7 | -0.3 |
| Other operating activities | 0.2 | -0.7 | 0.4 | -0.2 | 0.2 | -0.8 | 0.7 | 0.3 |
| Cash from operations | -6.8 | -4.0 | -4.9 | -6.1 | -3.7 | -5.5 | -6.5 | -5.3 |
| |
| Capital expenditures | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 |
| Purchases of property and equipment | | | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 |
| Other cash from investing | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | -1.3 | 1.9 | 0.0 |
| Cash from investing | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | -1.3 | 1.7 | 0.0 |
| |
| Issuance of common stock, net | 5.0 | 154.0 | | | | -150.8 | | |
| Other cash from financing | 0.3 | -150.8 | | | | 150.8 | -0.1 | |
| Cash from financing | 5.3 | 3.2 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 |
| |
| Free cash flow | -6.8 | -4.0 | -4.9 | -6.2 | -3.7 | -5.5 | -6.7 | -5.4 |
| Per share (diluted) | ($0.17) | ($0.11) | ($0.13) | ($0.17) | ($0.10) | ($0.15) | ($0.18) | ($0.15) |
|